BioSpace News Archive

New Leadership and Team to Further Company’s Commitment to Home Therapies

The Board of Directors of Portage Biotech Inc announces that Dr. Declan Doogan, the current Chief Executive Officer (“CEO”) has decided to step down with immediate effect.

Research Cell Banks Produce Therapeutic Proteins in Just Eight Weeks as Validated in Oral Presentation on Integration of Berkeley Lights’ Beacon Optofluidic Platform with Selexis’ Workflow and Clone Prediction Tool

Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions, today announced Dr. David Staskin presented positive, Phase 3 pivotal data demonstrating safety and efficacy of vibegron during a plenary session at the 2019 American Urological Association Annual Meeting (AUA) in Chicago yesterday afternoon.

XmAb23104, a PD-1 x ICOS bispecific antibody, is the sixth XmAb® antibody engineered with Xencor’s bispecific Fc domain to enter clinical development

The grant program challenges colleges and universities to work with faculty to examine and change campus cultures so that a diverse group of students feel included in science

Topline results from the study are expected in June 2019.

The American Academy of Neurology Annual Meeting is one of the largest gatherings of clinicians and researchers focusing on neurology in the world.

Macy’s joins the band of community partners looking to make a difference in the lives of women

Enters attractive Ohio market and plans for vertical integration in the state